Cite
HARVARD Citation
Keir, H. et al. (2022). Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. Lancet. 10 (12), pp. 1119-1128. [Online].